asthma medication adherence for children
DESCRIPTION
Asthma Medication Adherence for Children. Owen. Asthma. Asthma In the US. 10M CHILDREN. 50% PREVENTABLE. $15B IN COSTS. Main Existing Barriers. Adherence < 40%. Respiratory Diseases: Market Opportunity. WORLDWIDE 300M People With Respiratory Diseases *. US Total - PowerPoint PPT PresentationTRANSCRIPT
Asthma Medication Adherence for Children
Owen
2
AsthmaAsthma
3
10MCHILDREN $15B
IN COSTS
50%PREVENTABLE
AsthmaIn the US
4
5
Main Existing Barriers
Adherence < 40%
6
7
8
US Children’sAsthma
10M Children $15B
WORLDWIDE
300M People With Respiratory Diseases*
Respiratory Diseases: Market Opportunity
* Additional 100M people with asthma worldwide by 2025
9
The Adherence Problem = $317B in US
ADHDAnemiaCancer
DermatologyDiabetes
IBDMental Health
* Express Scripts: “$317B in excess health costs, 69% due to procrastination and forgetfulness”
10
US CHRONIC PEDI MEDICATION
Evolution of a m.Health startup in 2013:
• Gamification as a way to motivate people• How to be the best asthma consumer product• Design, UX, and UI• Who is our real customer? • ACO, a “great opportunity” for connected device
coverage?
11
The Beginning
Gamification as a way to motivate people
How to be the best asthma consumer product (and stay away from healthcare)
13
14
Design, UX, and UI Really Matter
Who is our real customer?
Kids(users &
beneficiaries)
Doctors(“trail guides”)
Parents(users &
beneficiaries)Friends
Other Caregivers
Parents of other kids with G.C.
Other kids with G.C.
Pharmacy/PBM(sellers)
Pharma(inhaler providers)
Data customers1
15
ACO, a “great opportunity” for connected
device reimbursement
?
16
Evolution of a m.Health Startup in 2013:
This is what bothers us NOW
• Clinically proven mobile products?
• What is the meaning of meaningful use of data?
• FDA / HIPPA / Privacy?
• What do risk holders want?
• Reimbursement process and CMS Coding for apps and mobile devices?
17
Clinically Proven, Self Managed
• Grants for non-regulated mobile apps
• RCT for mobile products• Hard to measure: what are the expected
outcomes?
• What is our place in the clinical workflow?
18
Meaningful Use of Data
• How do you show more than just what you measure?
• What will make a difference?
• How do you make the UX “one” with the user’s lifestyle?
19
FDA, FCC, CMS, ONC
OLD regulations for NEW Solutions•FDA regulations for mobile applications•Privacy: who handles all the healthcare data in the cloud?
Vs
20
What Do Risk Holders Want?
• Payers? PBMS? Drug manufacturers?
• How should we prove ROI, show clinical evidence, reduce costs?
• What can we sell? Hardware, Software, Data?
• Who will pay:
ConsumersConsumers
Pharma,PBMs
Pharma,PBMs
Payers, Providers
Payers, Providers
21
HSPCS, NDC, UDI, CPT, DRG, &%$#
New Solutions –
Old Payment Systems
•Reimbursement process and Coding
•CMS Accountable Care payment system?
22
